bluebird bio is focused on scaling its drug product deliveries and securing additional cash resources to achieve financial sustainability, aiming for positive cash flow in the near future.

With revenues expected to grow by a double-digit 11% over the next couple of years, the outlook is positive for Bio-Rad Laboratories. If the level of expenses is able to be maintained, it looks like ...

The global market for upstream bioprocessing equipment is on an accelerated growth trajectory, with a new market analysis by ...